Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 10705 | 15.625 |
09:34 ET | 13788 | 15.47 |
09:36 ET | 9544 | 15.52 |
09:38 ET | 15213 | 15.53 |
09:39 ET | 16795 | 15.53 |
09:41 ET | 3381 | 15.47 |
09:43 ET | 8193 | 15.7 |
09:45 ET | 6813 | 15.68 |
09:48 ET | 12446 | 15.72 |
09:50 ET | 5849 | 15.745 |
09:52 ET | 11007 | 15.84 |
09:54 ET | 16478 | 15.81 |
09:56 ET | 9700 | 15.69 |
09:57 ET | 6075 | 15.655 |
09:59 ET | 2060 | 15.7 |
10:01 ET | 8123 | 15.66 |
10:03 ET | 14914 | 15.66 |
10:06 ET | 22973 | 15.74 |
10:08 ET | 7064 | 15.66 |
10:10 ET | 4181 | 15.63 |
10:12 ET | 2993 | 15.62 |
10:14 ET | 7710 | 15.58 |
10:15 ET | 5951 | 15.55 |
10:17 ET | 2478 | 15.47 |
10:19 ET | 5930 | 15.47 |
10:21 ET | 1695 | 15.47 |
10:24 ET | 6089 | 15.49 |
10:26 ET | 5102 | 15.48 |
10:28 ET | 34216 | 15.45 |
10:30 ET | 5891 | 15.46 |
10:32 ET | 7623 | 15.45 |
10:33 ET | 4361 | 15.44 |
10:35 ET | 2500 | 15.3901 |
10:37 ET | 5349 | 15.3822 |
10:39 ET | 4200 | 15.365 |
10:42 ET | 3798 | 15.385 |
10:44 ET | 6717 | 15.37 |
10:46 ET | 2234 | 15.395 |
10:48 ET | 2901 | 15.4 |
10:50 ET | 2877 | 15.4 |
10:51 ET | 4941 | 15.47 |
10:53 ET | 2748 | 15.48 |
10:55 ET | 2539 | 15.51 |
10:57 ET | 28725 | 15.67 |
11:00 ET | 13763 | 15.6 |
11:02 ET | 7401 | 15.62 |
11:04 ET | 427 | 15.64 |
11:06 ET | 2706 | 15.68 |
11:08 ET | 3903 | 15.72 |
11:09 ET | 4329 | 15.7775 |
11:11 ET | 7405 | 15.77 |
11:13 ET | 7001 | 15.75 |
11:15 ET | 7087 | 15.77 |
11:18 ET | 2535 | 15.78 |
11:20 ET | 18562 | 15.75 |
11:22 ET | 18543 | 15.85 |
11:24 ET | 4674 | 15.8623 |
11:26 ET | 2089 | 15.85 |
11:27 ET | 6008 | 15.79 |
11:29 ET | 6734 | 15.79 |
11:31 ET | 4603 | 15.76 |
11:33 ET | 1227 | 15.7519 |
11:36 ET | 2442 | 15.77 |
11:38 ET | 3026 | 15.76 |
11:40 ET | 2863 | 15.74 |
11:42 ET | 3773 | 15.77 |
11:44 ET | 3738 | 15.78 |
11:45 ET | 1409 | 15.78 |
11:47 ET | 412 | 15.81 |
11:49 ET | 1485 | 15.83 |
11:51 ET | 11758 | 15.84 |
11:54 ET | 400 | 15.84 |
11:56 ET | 1682 | 15.865 |
11:58 ET | 7479 | 15.87 |
12:00 ET | 13580 | 15.825 |
12:02 ET | 4116 | 15.775 |
12:03 ET | 3851 | 15.805 |
12:05 ET | 19832 | 15.76 |
12:07 ET | 3898 | 15.75 |
12:09 ET | 8117 | 15.825 |
12:12 ET | 6740 | 15.775 |
12:14 ET | 6368 | 15.745 |
12:18 ET | 2493 | 15.76 |
12:20 ET | 6622 | 15.785 |
12:21 ET | 1042 | 15.81 |
12:23 ET | 2546 | 15.83 |
12:25 ET | 3842 | 15.85 |
12:27 ET | 990 | 15.845 |
12:30 ET | 4300 | 15.875 |
12:32 ET | 5657 | 15.905 |
12:34 ET | 5629 | 15.935 |
12:36 ET | 6864 | 15.95 |
12:38 ET | 1162 | 15.98 |
12:39 ET | 14228 | 15.97 |
12:41 ET | 1327 | 15.9512 |
12:43 ET | 200 | 15.95 |
12:45 ET | 5576 | 15.965 |
12:48 ET | 4750 | 15.94 |
12:50 ET | 1767 | 15.95 |
12:52 ET | 2845 | 15.95 |
12:54 ET | 3982 | 15.935 |
12:56 ET | 3803 | 15.93 |
12:57 ET | 589 | 15.94 |
12:59 ET | 1243 | 15.935 |
01:01 ET | 1754 | 15.96 |
01:03 ET | 484 | 15.98 |
01:06 ET | 1480 | 15.985 |
01:08 ET | 7431 | 15.935 |
01:10 ET | 1925 | 15.92 |
01:12 ET | 1631 | 15.93 |
01:14 ET | 1784 | 15.915 |
01:15 ET | 3926 | 15.9001 |
01:17 ET | 700 | 15.92 |
01:19 ET | 1563 | 15.91 |
01:21 ET | 652 | 15.915 |
01:24 ET | 986 | 15.92 |
01:26 ET | 396 | 15.91 |
01:28 ET | 8941 | 15.9 |
01:30 ET | 1316 | 15.905 |
01:32 ET | 1485 | 15.92 |
01:33 ET | 2138 | 15.94 |
01:35 ET | 887 | 15.95 |
01:37 ET | 6492 | 15.925 |
01:39 ET | 3163 | 15.91 |
01:42 ET | 1740 | 15.91 |
01:44 ET | 4552 | 15.915 |
01:46 ET | 714 | 15.92 |
01:48 ET | 6629 | 15.88 |
01:50 ET | 1595 | 15.8589 |
01:51 ET | 950 | 15.85 |
01:53 ET | 5346 | 15.835 |
01:55 ET | 5712 | 15.8 |
01:57 ET | 2481 | 15.81 |
02:00 ET | 905 | 15.815 |
02:02 ET | 2146 | 15.805 |
02:04 ET | 4855 | 15.7948 |
02:06 ET | 5491 | 15.81 |
02:08 ET | 800 | 15.805 |
02:09 ET | 4383 | 15.795 |
02:11 ET | 1816 | 15.815 |
02:13 ET | 1704 | 15.825 |
02:15 ET | 9606 | 15.93 |
02:18 ET | 46915 | 15.95 |
02:20 ET | 15985 | 15.915 |
02:22 ET | 2500 | 15.92 |
02:24 ET | 3529 | 15.94 |
02:26 ET | 2330 | 15.935 |
02:29 ET | 4705 | 15.88 |
02:31 ET | 2761 | 15.87 |
02:33 ET | 7197 | 15.858 |
02:36 ET | 7919 | 15.81 |
02:38 ET | 2475 | 15.795 |
02:40 ET | 1462 | 15.8 |
02:42 ET | 500 | 15.79 |
02:44 ET | 6809 | 15.775 |
02:45 ET | 3557 | 15.785 |
02:47 ET | 14260 | 15.79 |
02:49 ET | 3234 | 15.78 |
02:51 ET | 652 | 15.78 |
02:54 ET | 200 | 15.78 |
02:56 ET | 8746 | 15.76 |
02:58 ET | 2199 | 15.735 |
03:00 ET | 4955 | 15.74 |
03:02 ET | 6184 | 15.74 |
03:03 ET | 3775 | 15.71 |
03:05 ET | 6520 | 15.7 |
03:07 ET | 4265 | 15.67 |
03:09 ET | 11699 | 15.645 |
03:12 ET | 1088 | 15.645 |
03:14 ET | 7299 | 15.6 |
03:16 ET | 14991 | 15.61 |
03:18 ET | 31770 | 15.66 |
03:20 ET | 31067 | 15.68 |
03:21 ET | 6600 | 15.66 |
03:23 ET | 7526 | 15.64 |
03:25 ET | 6889 | 15.635 |
03:27 ET | 14803 | 15.63 |
03:30 ET | 1200 | 15.635 |
03:32 ET | 14143 | 15.605 |
03:34 ET | 22657 | 15.685 |
03:36 ET | 12032 | 15.65 |
03:38 ET | 4586 | 15.68 |
03:39 ET | 12710 | 15.645 |
03:41 ET | 6302 | 15.64 |
03:43 ET | 6890 | 15.645 |
03:45 ET | 10277 | 15.635 |
03:48 ET | 13189 | 15.64 |
03:50 ET | 8376 | 15.68 |
03:52 ET | 11787 | 15.675 |
03:54 ET | 12551 | 15.67 |
03:56 ET | 30025 | 15.655 |
03:57 ET | 29325 | 15.63 |
03:59 ET | 322247 | 15.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.6B | 86.2x | --- |
Azenta Inc | 2.7B | -19.6x | --- |
Guardant Health Inc | 3.6B | -7.1x | --- |
PTC Therapeutics Inc | 2.4B | -5.0x | --- |
Amicus Therapeutics Inc | 3.4B | -28.9x | --- |
Denali Therapeutics Inc | 3.2B | -7.8x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 86.2x |
Price/Sales (TTM) | 2.9 |
Price/Cash Flow (TTM) | 61.7x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.